Concepedia

Author

Nilanjan Adhikari

Jadavpur UniversityORCID

Also Known As

Adhikari, Narayan S., Emara, Omar, N. Adhikari, Nayan Adhikari, Neha Adhikari, Nilanajn Adhikari, Nilanjan Adhikari

167

Publications

3.8K

Citations

32

H-Index

63

Concepts

All Affiliations

Jadavpur UniversityBirla Institute of Technology and Science, PilaniDr. Hari Singh Gour UniversityBirla Institute of Technology and Science - Hyderabad CampusUniversity of Calcutta
NA

About

Nilanjan Adhikari is an author at Jadavpur University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

45

1.2K

2

Natural Sciences

19

32

945

3

Biochemistry

17

26

781

4

Engineering

4

4

87

5

Biomolecular Engineering

3

3

96

Nilanjan Adhikari

×

75

Publications

1.8K

Citations

25

H-Index

YearCitations

Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors

Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee,

Computers in Biology and Medicine

2023

98

Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects

Prakruti Trivedi, Nilanjan Adhikari, Sk. Abdul Amin,

European Journal of Pharmaceutical Sciences

2018

59

Exploring pyrazolo[3,4-<i>d</i>]pyrimidine phosphodiesterase 1 (PDE1) inhibitors: a predictive approach combining comparative validated multiple molecular modelling techniques

Sk. Abdul Amin, Sonam Bhargava, Nilanjan Adhikari,

Journal of Biomolecular Structure and Dynamics

2017

56

Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery

Tarun Patel, Nilanjan Adhikari, Sk. Abdul Amin,

New Journal of Chemistry

2021

56

Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays

Nilanjan Adhikari, Amit Kumar Halder, Sumana Mallick,

Bioorganic & Medicinal Chemistry

2016

53

Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer

Sravani Pulya, Ambati Himaja, Milan Paul,

Journal of Medicinal Chemistry

2023

48

Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches

Sandip Kumar Baidya, Suvankar Banerjee, Balaram Ghosh,

SAR and QSAR in environmental research

2023

46

First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington’s disease: A proposal to chemists!

Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha,

Bioorganic & Medicinal Chemistry Letters

2016

45

First report on the structural exploration and prediction of new BPTES analogs as glutaminase inhibitors

Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen,

Journal of Molecular Structure

2017

42

Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity

Prakruti Trivedi, Nilanjan Adhikari, Sk. Abdul Amin,

European Journal of Pharmaceutical Sciences

2019

42

Page 1